ARDS幸存者躯体功能测量与患者中心结局的关联
该研究基于两项美国前瞻性队列(N=134和N=99)的6个月幸存者数据,分析躯体功能测量与患者中心结局的关联。结果显示,身体功能与结构测量与结局无一致关联,而活动与参与测量与SF-36躯体成分评分及EQ-5D效用评分相关,建议将参与测量作为未来研究的核心指标。
要点
- 身体功能与结构测量与ARDS后6或12个月患者中心结局无一致关联
- 6分钟步行试验与6个月SF-36躯体成分评分相关
- 参与测量(FPI、IADL)与SF-36 PCS及EQ-5D效用评分相关,推荐作为核心测量
核心结论
- 在ARDS后12个月内,参与测量比身体功能与结构测量更能反映患者生活质量,推荐作为未来研究的核心测量。
研究设计与样本
- 研究为二次分析,纳入美国多中心前瞻性研究(ARDSNet长期结局研究,N=134)和巴尔的摩多站点前瞻性研究(N=99)的6个月幸存者。
- 躯体功能测量在6个月随访时评估,按WHO国际功能分类分为身体功能与结构、活动与参与三类。
- 患者中心结局在6和12个月评估,包括生存、住院、居家存活状态和健康相关生活质量。
- 采用Pearson相关、线性回归和逻辑回归模型量化关联。
主要发现
- 多变量回归中,6个月身体功能与结构测量与6或12个月结局无一致关联。
- 6分钟步行试验与6个月SF-36躯体成分评分相关(β范围0.99-1.52,p<0.05)。
- 参与测量(FPI、IADL)与6和12个月SF-36 PCS相关(β范围:FPI 1.51-1.52;IADL -1.88至-1.32;均p<0.05)。
- 参与测量与6和12个月EQ-5D效用评分相关(β范围:FPI 2.00-3.67;IADL -2.89至-2.50;均p<0.01)。
临床怎么用
- 在ARDS幸存者随访中,优先采用参与测量(如FPI、IADL)评估患者生活质量。
- 6分钟步行试验可作为活动相关结局的补充测量。
- 身体功能与结构测量不宜单独作为ARDS后患者中心结局的替代指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To inform selection of physical measures for studies of acute respiratory distress syndrome (ARDS) survivors within 12 months of ARDS. METHODS: Secondary analysis of data from 6-month survivors participating in a US multicentre prospective study (ARDSNet Long-Term Outcome Study, N=134) or a multisite prospective study in Baltimore, Maryland, USA (Improving Care of Acute Lung Injury Patients, N=99). Physical measures, assessed at 6-month follow-up, were categorised according to the WHO's International Classification of Disability and Health: body functions and structures, activity and participation. Patient-centred outcomes were evaluated at 6 and 12 months: survival, hospitalisation, alive at home status and health-related quality of life. Pearson correlation, linear and logistic regression models were used to quantify associations of physical measures with patient-centred outcomes. MAIN RESULTS: No 6-month body functions and structures measure demonstrated consistent association with 6-month or 12-month outcomes in multivariable regression. The 6 min walk test, an activity measure, was associated with 6-month Short-Form 36 (SF-36) physical component scores (PCS, β range: 0.99 to 1.52, p<0.05). Participation measures (Functional Performance Inventory, FPI; Instrumental Activities of Daily Living, IADLs) were associated with SF-36 PCS (β range: FPI, 1.51-1.52; IADL, -1.88 to -1.32; all p<0.05) and Euro-QOL-5D utility score (β range: FPI, 2.00-3.67; IADL, -2.89 to -2.50; all p<0.01) at 6 and 12 months. CONCLUSIONS: Participation measures better reflect patient's quality of life than measures of body functions and structures within 12 months of ARDS among 6-month survivors, and are recommended for inclusion as a core measure in future studies.
引用
- Chan KS, Aronson Friedman L, Dinglas VD, et al. Are physical measures related to patient-centred outcomes in ARDS survivors? Thorax. 2017. PMID: 28108621. doi:10.1136/thoraxjnl-2016-209400
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。